Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Japanese researchers synthesize new PROTACs for cancer

Sep. 1, 2021

Fileclo Sp zoo discloses new compounds for cancer

Sep. 1, 2021

Novel oxidative-phosphorylation inhibitors with promising antitumor activity in vivo

Sep. 1, 2021

New class of Mcl-1 inhibitors developed at Janssen for treating myeloma

Aug. 31, 2021

Low-dose targeted radionuclide therapy using [90Y]NM-600 promotes response to ICIs

Aug. 31, 2021

New benzimidazole derivative as a selective RORgamma inverse agonist for prostate cancer treatment

Aug. 31, 2021

TroBio Therapeutics presents new compounds for cancer

Aug. 31, 2021

Janssen Biotech divulges DHODH inhibitors

Aug. 31, 2021

TH-1902, a new docetaxel-peptide conjugate with efficacy in SORT1-positive TNBC models

Aug. 30, 2021

CELMoD CC-99282 for hematological malignancies

Aug. 30, 2021

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...